Dabur India Ltd

Dabur India Ltd

₹ 484 1.72%
21 May 10:05 a.m.
About

Dabur is India’s leading FMCG, Ayurvedic and natural health care companies with wide network distribution across world. [1]

Key Points

Leading FMCG Company Dabur India Limited is the fourth largest FMCG Company in India and the world’s largest Ayurvedic and Natural Health Care Company with a portfolio of over 250 Herbal/Ayurvedic products.[1]

  • Market Cap 85,780 Cr.
  • Current Price 484
  • High / Low 672 / 420
  • Stock P/E 49.3
  • Book Value 60.9
  • Dividend Yield 1.15 %
  • ROCE 20.3 %
  • ROE 16.8 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 62.4%

Cons

  • Stock is trading at 7.81 times its book value
  • The company has delivered a poor sales growth of 7.66% over past five years.
  • Working capital days have increased from 24.3 days to 61.0 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
2,518 2,822 2,986 3,043 2,678 3,130 3,204 3,255 2,815 3,349 3,029 3,355 2,830
2,065 2,279 2,386 2,434 2,268 2,526 2,543 2,588 2,348 2,694 2,476 2,673 2,403
Operating Profit 452 543 600 609 410 605 661 667 466 655 553 682 427
OPM % 18% 19% 20% 20% 15% 19% 21% 20% 17% 20% 18% 20% 15%
14 101 123 101 121 110 117 127 129 129 152 129 141
Interest 12 12 15 19 32 24 28 36 35 33 47 44 39
Depreciation 65 68 70 71 102 97 98 97 107 109 111 109 117
Profit before tax 390 564 638 620 396 593 651 661 453 642 546 658 412
Tax % 24% 22% 23% 23% 26% 23% 22% 23% 25% 23% 24% 22% 24%
294 441 491 477 293 457 507 506 341 494 418 516 313
EPS in Rs 1.66 2.49 2.77 2.69 1.70 2.62 2.91 2.90 1.97 2.82 2.40 2.95 1.81
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
7,058 7,795 7,780 7,614 7,722 8,515 8,685 9,562 10,889 11,530 12,404 12,563
5,897 6,475 6,261 6,102 6,104 6,775 6,892 7,560 8,637 9,367 10,004 10,247
Operating Profit 1,162 1,320 1,518 1,512 1,617 1,740 1,792 2,002 2,252 2,162 2,400 2,316
OPM % 16% 17% 20% 20% 21% 20% 21% 21% 21% 19% 19% 18%
126 154 217 296 291 222 205 325 308 445 482 551
Interest 54 40 48 54 53 60 50 31 39 78 124 164
Depreciation 97 115 133 143 162 177 220 240 253 311 399 446
Profit before tax 1,136 1,319 1,554 1,611 1,693 1,725 1,728 2,056 2,269 2,219 2,359 2,258
Tax % 19% 19% 19% 21% 20% 16% 16% 18% 23% 23% 23% 23%
916 1,068 1,254 1,280 1,358 1,446 1,448 1,695 1,742 1,701 1,811 1,740
EPS in Rs 5.24 6.07 7.11 7.25 7.69 8.17 8.18 9.58 9.84 9.64 10.40 9.97
Dividend Payout % 33% 33% 32% 31% 81% 34% 37% 50% 53% 54% 53% 80%
Compounded Sales Growth
10 Years: 5%
5 Years: 8%
3 Years: 5%
TTM: 1%
Compounded Profit Growth
10 Years: 5%
5 Years: 3%
3 Years: -1%
TTM: -4%
Stock Price CAGR
10 Years: 6%
5 Years: 2%
3 Years: -2%
1 Year: -12%
Return on Equity
10 Years: 23%
5 Years: 20%
3 Years: 18%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 174 176 176 176 176 177 177 177 177 177 177 177
Reserves 2,482 3,178 3,995 4,671 5,530 5,455 6,429 7,487 8,205 8,796 9,689 10,623
708 734 805 975 938 699 522 509 1,030 1,174 1,365 950
1,948 2,019 1,956 1,910 2,058 2,106 2,209 2,661 2,872 3,505 3,885 4,481
Total Liabilities 5,312 6,106 6,932 7,732 8,702 8,437 9,337 10,833 12,284 13,652 15,116 16,232
1,767 1,877 1,667 1,958 2,028 1,969 2,253 2,243 2,308 3,579 3,815 3,992
CWIP 22 50 45 42 42 64 147 147 168 175 232 166
Investments 1,076 1,813 2,691 3,240 3,805 3,359 2,800 4,160 6,220 6,265 6,933 7,468
2,447 2,365 2,529 2,492 2,827 3,045 4,137 4,283 3,589 3,633 4,136 4,606
Total Assets 5,312 6,106 6,932 7,732 8,702 8,437 9,337 10,833 12,284 13,652 15,116 16,232

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,098 1,047 1,187 1,227 1,092 1,499 1,614 2,115 1,802 1,488 2,013 1,987
-104 -876 -730 -807 -541 338 -517 -1,404 -1,273 -583 -971 -449
-804 -417 -374 -339 -577 -1,888 -1,043 -613 -490 -1,035 -1,161 -1,405
Net Cash Flow 190 -245 82 81 -27 -51 54 97 38 -130 -119 132

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 35 33 38 31 33 36 34 21 22 27 26 26
Inventory Days 150 136 150 153 169 154 164 178 169 158 149 128
Days Payable 169 153 182 181 190 172 176 197 178 171 186 158
Cash Conversion Cycle 16 16 6 3 13 17 22 3 12 14 -10 -4
Working Capital Days 2 7 21 14 21 16 22 5 7 10 2 61
ROCE % 35% 36% 35% 31% 28% 28% 28% 27% 27% 23% 22% 20%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
67.24% 67.23% 66.23% 66.23% 66.23% 66.24% 66.25% 66.26% 66.25% 66.25% 66.27% 66.28%
20.23% 20.24% 20.47% 19.73% 19.39% 18.37% 16.49% 15.82% 14.99% 15.05% 13.28% 12.68%
4.04% 6.57% 7.48% 8.31% 8.75% 9.78% 11.66% 12.46% 13.45% 13.57% 14.85% 15.62%
0.00% 0.06% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07%
8.50% 5.89% 5.74% 5.65% 5.57% 5.53% 5.54% 5.40% 5.26% 5.07% 5.53% 5.36%
No. of Shareholders 4,83,5604,57,4904,43,6184,48,9754,44,8324,33,5014,39,1234,34,8234,35,2134,30,4365,10,2985,05,557

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls